HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
HIMS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS is valued quite expensively, but it does show have an excellent growth rating. These ratings could make HIMS a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of HIMS (18.44%) is better than 100.00% of its industry peers.
The Return On Equity of HIMS (29.93%) is better than 95.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.93%, HIMS belongs to the top of the industry, outperforming 91.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROIC | 14.93% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 9.21%. This is amongst the best in the industry. HIMS outperforms 93.20% of its industry peers.
Looking at the Operating Margin, with a value of 6.48%, HIMS is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
HIMS has a better Gross Margin (77.04%) than 91.26% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HIMS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
HIMS has an Altman-Z score of 21.13. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS's Altman-Z score of 21.13 is amongst the best of the industry. HIMS outperforms 97.09% of its industry peers.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 21.13 |
ROIC/WACC1.65
WACC9.07%
2.3 Liquidity
HIMS has a Current Ratio of 1.59. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Current ratio of 1.59. This is comparable to the rest of the industry: HIMS outperforms 55.34% of its industry peers.
A Quick Ratio of 1.32 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a Quick ratio of 1.32. This is comparable to the rest of the industry: HIMS outperforms 48.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 7000.00%, which is quite impressive.
The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
The Revenue has grown by 85.99% in the past year. This is a very strong growth!
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
The Revenue is expected to grow by 24.96% on average over the next years. This is a very strong growth
EPS Next Y26.18%
EPS Next 2Y33.82%
EPS Next 3Y33.56%
EPS Next 5Y41.75%
Revenue Next Year60.27%
Revenue Next 2Y38.58%
Revenue Next 3Y32.36%
Revenue Next 5Y24.96%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 69.41, which means the current valuation is very expensive for HIMS.
HIMS's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (27.41), we can say HIMS is valued expensively.
The Price/Forward Earnings ratio is 49.53, which means the current valuation is very expensive for HIMS.
HIMS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.19. HIMS is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.41 | ||
| Fwd PE | 49.53 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HIMS is valued a bit more expensive than 62.14% of the companies in the same industry.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.32 | ||
| EV/EBITDA | 75.02 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 33.56% in the coming years.
PEG (NY)2.65
PEG (5Y)1.15
EPS Next 2Y33.82%
EPS Next 3Y33.56%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
47.89
-2.38 (-4.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.96%
Inst Owner Change0%
Ins Owners10.67%
Ins Owner Change12.07%
Market Cap10.72B
Analysts70
Price Target50.08 (4.57%)
Short Float %32.33%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.39%
Min EPS beat(2)4.62%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)192.83%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)156.65%
EPS beat(12)11
Avg EPS beat(12)110.67%
EPS beat(16)12
Avg EPS beat(16)78.36%
Revenue beat(2)2
Avg Revenue beat(2)3.52%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.75%
Revenue beat(4)4
Avg Revenue beat(4)3.3%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.56%
Revenue beat(12)10
Avg Revenue beat(12)2.89%
Revenue beat(16)14
Avg Revenue beat(16)3.76%
PT rev (1m)4.4%
PT rev (3m)11.83%
EPS NQ rev (1m)4.69%
EPS NQ rev (3m)1.73%
EPS NY rev (1m)7.74%
EPS NY rev (3m)10.34%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-2.95%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)1.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.41 | ||
| Fwd PE | 49.53 | ||
| P/S | 6.01 | ||
| P/FCF | 45.32 | ||
| P/OCF | 32.06 | ||
| P/B | 19.52 | ||
| P/tB | 27.62 | ||
| EV/EBITDA | 75.02 |
EPS(TTM)0.69
EY1.44%
EPS(NY)0.97
Fwd EY2.02%
FCF(TTM)1.06
FCFY2.21%
OCF(TTM)1.49
OCFY3.12%
SpS7.97
BVpS2.45
TBVpS1.73
PEG (NY)2.65
PEG (5Y)1.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROCE | 18.9% | ||
| ROIC | 14.93% | ||
| ROICexc | 31.63% | ||
| ROICexgc | 71.61% | ||
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% | ||
| FCFM | 13.25% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 437.46% | ||
| Cap/Sales | 5.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 242.39% | ||
| Profit Quality | 143.86% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 21.13 |
F-Score6
WACC9.07%
ROIC/WACC1.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
EPS Next Y26.18%
EPS Next 2Y33.82%
EPS Next 3Y33.56%
EPS Next 5Y41.75%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
Revenue Next Year60.27%
Revenue Next 2Y38.58%
Revenue Next 3Y32.36%
Revenue Next 5Y24.96%
EBIT growth 1Y2214.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year366.35%
EBIT Next 3Y97.77%
EBIT Next 5Y66.66%
FCF growth 1Y3973.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14096.9%
OCF growth 3YN/A
OCF growth 5YN/A